143 related articles for article (PubMed ID: 22533676)
1. Detection of mitochondrial DNA mutations in nonmuscle invasive bladder cancer.
Guney AI; Ergec DS; Tavukcu HH; Koc G; Kirac D; Ulucan K; Javadova D; Turkeri L
Genet Test Mol Biomarkers; 2012 Jul; 16(7):672-8. PubMed ID: 22533676
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer.
Chen GF; Chan FL; Hong BF; Chan LW; Chan PS
Oncol Rep; 2004 Aug; 12(2):463-72. PubMed ID: 15254717
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.
Wada T; Tanji N; Ozawa A; Wang J; Shimamoto K; Sakayama K; Yokoyama M
Anticancer Res; 2006; 26(5A):3403-8. PubMed ID: 17094459
[TBL] [Abstract][Full Text] [Related]
4. Analysis of fluorescence in situ hybridization, mtDNA quantification, and mtDNA sequence for the detection of early bladder cancer.
Yoo JH; Suh B; Park TS; Shin MG; Choi YD; Lee CH; Choi JR
Cancer Genet Cytogenet; 2010 Apr; 198(2):107-17. PubMed ID: 20362225
[TBL] [Abstract][Full Text] [Related]
5. Performance of mitochondrial DNA mutations detecting early stage cancer.
Jakupciak JP; Maragh S; Markowitz ME; Greenberg AK; Hoque MO; Maitra A; Barker PE; Wagner PD; Rom WN; Srivastava S; Sidransky D; O'Connell CD
BMC Cancer; 2008 Oct; 8():285. PubMed ID: 18834532
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial D310 instability in Chinese lung cancer patients.
Chen XZ; Fang Y; Shi YH; Cui JH; Li LY; Xu YC; Ling B
Mitochondrial DNA A DNA Mapp Seq Anal; 2016; 27(2):1177-80. PubMed ID: 25010070
[TBL] [Abstract][Full Text] [Related]
7. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids.
Fliss MS; Usadel H; Caballero OL; Wu L; Buta MR; Eleff SM; Jen J; Sidransky D
Science; 2000 Mar; 287(5460):2017-9. PubMed ID: 10720328
[TBL] [Abstract][Full Text] [Related]
8. [Mitochondrial DNA mutations in lung cancer].
Jin XJ; Zhang JJ; Song Y; Gao YN; Cheng SJ
Ai Zheng; 2002 Jul; 21(7):715-8. PubMed ID: 12479093
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA mutations in pancreatic cancer.
Kassauei K; Habbe N; Mullendore ME; Karikari CA; Maitra A; Feldmann G
Int J Gastrointest Cancer; 2006; 37(2-3):57-64. PubMed ID: 17827523
[TBL] [Abstract][Full Text] [Related]
10. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutations of mitochondrial DNA in digestive tract cancers.
Kose K; Hiyama T; Tanaka S; Yoshihara M; Yasui W; Chayama K
J Gastroenterol Hepatol; 2005 Nov; 20(11):1679-84. PubMed ID: 16246185
[TBL] [Abstract][Full Text] [Related]
14. Role of mitochondrial DNA mutations in brain tumors: A mini-review.
Mohamed Yusoff AA
J Cancer Res Ther; 2015; 11(3):535-44. PubMed ID: 26458578
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
16. Mutations of mitochondrial DNA as potential biomarkers in breast cancer.
Cai FF; Kohler C; Zhang B; Chen WJ; Barekati Z; Garritsen HS; Lenner P; Toniolo P; Zhang JJ; Zhong XY
Anticancer Res; 2011 Dec; 31(12):4267-71. PubMed ID: 22199290
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutation in mitochondrial DNA and nuclear microsatellite instability in gastric cancer.
Hiyama T; Tanaka S; Shima H; Kose K; Tuncel H; Ito M; Kitadai Y; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K
Oncol Rep; 2003; 10(6):1837-41. PubMed ID: 14534705
[TBL] [Abstract][Full Text] [Related]
18. Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma.
Kumimoto H; Yamane Y; Nishimoto Y; Fukami H; Shinoda M; Hatooka S; Ishizaki K
Int J Cancer; 2004 Jan; 108(2):228-31. PubMed ID: 14639607
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of the mitochondrial genome in human breast cancers.
Tseng LM; Yin PH; Yang CW; Tsai YF; Hsu CY; Chi CW; Lee HC
Genes Chromosomes Cancer; 2011 Oct; 50(10):800-11. PubMed ID: 21748819
[TBL] [Abstract][Full Text] [Related]
20. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
